Union Bancaire Privee UBP SA Purchases New Position in Ventas, Inc. $VTR

Union Bancaire Privee UBP SA acquired a new position in Ventas, Inc. (NYSE:VTR) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 17,251 shares of the real estate investment trust’s stock, valued at approximately $1,335,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Arbor Capital Management Inc. ADV grew its position in Ventas by 0.6% in the third quarter. Arbor Capital Management Inc. ADV now owns 21,716 shares of the real estate investment trust’s stock worth $1,520,000 after acquiring an additional 137 shares in the last quarter. Foundations Investment Advisors LLC increased its stake in shares of Ventas by 3.3% during the 3rd quarter. Foundations Investment Advisors LLC now owns 4,447 shares of the real estate investment trust’s stock worth $311,000 after purchasing an additional 144 shares during the last quarter. Ameritas Investment Partners Inc. raised its holdings in shares of Ventas by 3.8% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,260 shares of the real estate investment trust’s stock valued at $269,000 after purchasing an additional 155 shares in the last quarter. Checchi Capital Advisers LLC raised its holdings in shares of Ventas by 3.9% during the 3rd quarter. Checchi Capital Advisers LLC now owns 4,603 shares of the real estate investment trust’s stock valued at $322,000 after purchasing an additional 174 shares in the last quarter. Finally, Parallel Advisors LLC lifted its stake in shares of Ventas by 4.6% in the 3rd quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock valued at $278,000 after purchasing an additional 175 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Insider Buying and Selling

In related news, EVP Carey S. Roberts sold 35,532 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the transaction, the executive vice president directly owned 72,755 shares in the company, valued at $6,184,175. The trade was a 32.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Robert F. Probst sold 29,930 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the transaction, the chief financial officer directly owned 138,434 shares of the company’s stock, valued at approximately $10,694,026.50. This trade represents a 17.78% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 86,106 shares of company stock valued at $6,931,397 over the last three months. 0.80% of the stock is owned by corporate insiders.

Ventas Stock Performance

Shares of NYSE VTR opened at $82.46 on Friday. Ventas, Inc. has a 12 month low of $60.15 and a 12 month high of $88.36. The company has a market cap of $39.16 billion, a P/E ratio of 152.70, a P/E/G ratio of 2.04 and a beta of 0.73. The business’s 50 day moving average is $82.51 and its two-hundred day moving average is $77.03. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.74). The company had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The company’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, equities analysts expect that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be paid a $0.52 dividend. The ex-dividend date is Tuesday, March 31st. This is a boost from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Ventas’s dividend payout ratio is 355.56%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. Weiss Ratings upgraded shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Scotiabank boosted their price target on Ventas from $80.00 to $93.00 and gave the stock a “sector perform” rating in a research report on Monday, March 2nd. JPMorgan Chase & Co. upped their price target on Ventas from $88.00 to $93.00 and gave the stock an “overweight” rating in a research note on Friday. UBS Group reissued a “neutral” rating and set a $85.00 price objective on shares of Ventas in a report on Monday, February 9th. Finally, KeyCorp raised their price objective on Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $90.13.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.